MENU
GOSS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Gossamer Bio (GOSS) Ownership - Who owns Gossamer Bio?

Gossamer Bio Inc is a clinical-stage biopharmaceutical company... Show more

Profile

Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
281.85M
P/E Ratio
N/A
Total Cash
257.93M
Projected Growth
N/A
Total Debt
202.79M
Revenue
124.59M
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash/Share
1.13
Total Debt/Equity
N/A
Revenue/Share
0.55 USD as % of share price

Fundamentals

GOSS
Capitalization
282M
P/E Ratio
N/A
Risk (Beta)
2.32
Dividend Yield
N/A
Total Cash
258M
Total Cash/Share
1.13
Total Debt
203M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.55%
Revenue
125M
ROE
N/A
Book Value
-6.25M
P/B Ratio
8.09
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
23K
Current Ratio
5.71
Current Revenue Per Employee
68200.00
Dividends Per Share - Security
N/A
EBITDA
-35.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-18.98
Shares Held By Institutions
198M
Shares Outstanding - Current
227M
Total Liabilities
287M
Total Volume MTD
N/A
Value
N/A
Gain YTD
38.183
View a ticker or compare two or three
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
3013 Science Park Road
Phone
+1 858 684-1300
Employees
135
Web
https://www.gossamerbio.com